New formulation helps RNA vaccines withstand high temperatures
RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer. One drawback is that they require ultracold storage, but MIT researchers have found a promising way to overcome that limitation.
RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer. One drawback is that they require ultracold storage, but MIT researchers have found a promising way to overcome that limitation. This story matters for Science & Discovery readers tracking insect. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InsectNews curates and briefs the science & discovery stories that matter. Our editorial policy →